Skip to main content
SpringerLink
Log in

Clopidogrel (II): Conferring over the Kung Pao

Clopidogrel, proton pump inhibitors, calcium channel blockers, CYP2C19, CYP3A4

  • Chapter
A Case Approach to Perioperative Drug-Drug Interactions

  • 94 Accesses

Abstract

This case further discusses the aggregation of risk factors for significant drug–drug interactions involving clopidogrel, proton pump inhibitors, and calcium channel blockers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Drepper MD, Spahr L, Frossard JL, et al. Clopidogrel and proton pump inhibitors – where do we stand in 2012? World J Gastroenterol. 2012;18(18):2161–71.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  2. Gremmel T, Steiner S, Seidinger D, et al. Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition. Heart. 2010;96(3):186–9.

    Article  PubMed  CAS  Google Scholar 

  3. Harmsze AM, van Werkum JW, Souverein PC, et al. Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention. J Thromb Haemost. 2011;9(10):1892–901.

    Article  PubMed  CAS  Google Scholar 

  4. Siller-Matula JM, Lang I, Christ G, et al. Calcium-channel blockers reduce the antiplatelet effect of clopidogrel. J Am Coll Cardiol. 2008;52(19):1557–63.

    Article  PubMed  CAS  Google Scholar 

  5. Bhurke SM, Martin BC, Li C, et al. Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome. Pharmacotherapy. 2012;32(9):809–18.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Fontes-Carvalho R, Albuquerque A, Araújo C, et al. Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction. Eur J Gastroenterol Hepatol. 2011;23(5):396–404.

    Article  PubMed  CAS  Google Scholar 

  7. Schmidt M, Johansen MB, Robertson DJ, et al. Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events. Eur J Clin Invest. 2012;42(3):266–74. Epub 2011 Aug 11.

    Article  PubMed  CAS  Google Scholar 

  8. Kwok CS, Jeevanantham V, Dawn B, et al. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis. Int J Cardiol. 2013;167(3):965–74.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Anesthesia Services Department, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA

    Catherine Marcucci MD

  2. Department of Psychiatry, University of Maryland Medical System, Baltimore, MD, USA

    Neil B. Sandson MD

  3. Department of Psychiatry, VA Maryland Health Care System, Baltimore, MD, USA

    Neil B. Sandson MD

Authors
  1. Catherine Marcucci MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neil B. Sandson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Catherine Marcucci MD .

Editor information

Editors and Affiliations

  1. Anesthesia Services Department, Philadelphia Veterans Affairs Med Center, Philadelphia, PA, USA

    Catherine Marcucci MD

  2. Department of Anesthesiology, Oregon Health and Science University, Portland, OR, USA

    Michael P. Hutchens MD

  3. Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA

    Erica D. Wittwer MD, PhD , Toby N. Weingarten MD , Juraj Sprung MD, PhD  & Wayne T. Nicholson MD, PharmD, MSc , ,  & 

  4. Department of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, OR, USA

    Kirk Lalwani MD

  5. Department of Anesthesiology, University of Pittsburgh School of Med Liliane S. Kaufmann Building, Pittsburgh, PA, USA

    David G. Metro MD

  6. Department of Anesthesiology, University of Illinois at Chicago, Chicago, IL, USA

    Randal O. Dull MD, PhD

  7. Department of Anesthesiology, Perioperative Medicine, Oregon Health and Science University, Portland, OR, USA

    Christopher E. Swide MD

  8. Department of Learning Health Sciences, University of Michigan Medical School, Ann Arbor, MI, USA

    F. Jacob Seagull PhD

  9. Department of Anesthesiology and Perioperative Medicine, Portland, OR, USA

    Jeffrey R. Kirsch MD (Professor and Chair) (Professor and Chair)

  10. Department of Psychiatry, University of Maryland Medical System VA Maryland Health Care System, Baltimore, MD, USA

    Neil B. Sandson MD

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Marcucci, C., Sandson, N.B. (2015). Clopidogrel (II): Conferring over the Kung Pao. In: Marcucci, C., et al. A Case Approach to Perioperative Drug-Drug Interactions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7495-1_152

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7495-1_152

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7494-4

  • Online ISBN: 978-1-4614-7495-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation